Biotech entity
pharma is the sole category represented across all 1 tracked stories. Lassa Fever is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Nigeria, all published on March 16, 2026.
Last mentioned: Jul 12, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Lassa Fever is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Nigeria, all published on March 16, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 13 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Nigeria. Shared-story counts are live from our verified record — not editorial picks.
NCDC Report
Official confirmation that the death toll has reached 109 fatalities.
Infection Peak
Weekly new infections begin to show a statistical decline.
Outbreak Commencement
Start of the 2026 Lassa fever seasonal peak in Nigeria.
Nigeria's Lassa fever death toll has climbed to 109 in 2026, even as the Nigeria Centre for Disease Control (NCDC) reports a downward trend in new weekly infections. The persistent mortality rate highlights critical gaps in early diagnosis and the urgent need for specialized therapeutics in endemic regions.
Nigeria is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
